2024MAY03: Our hosting provider has resolved some DB connectivity issues. We may experience some more outages as the issue is resolved. We apologize for the inconvenience. Dismiss and don't show again

Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

This service exclusively searches for literature that cites resources. Please be aware that the total number of searchable documents is limited to those containing RRIDs and does not include all open-access literature.

Search

Type in a keyword to search

On page 1 showing 1 ~ 20 papers out of 127 papers

Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.

  • Jyoti Mayadev‎ et al.
  • Gynecologic oncology‎
  • 2018‎

The treatment for locally advanced cervical cancer is external beam radiation (EBRT), concurrent chemotherapy, and brachytherapy (BT). We investigated demographic and socioeconomic factors that influence trends in BT utilization and disparities in survival.


Global incidence comparisons and trends in ovarian germ cell tumors by geographic region in girls, adolescents and young women: 1988-2012.

  • Aubrey K Hubbard‎ et al.
  • Gynecologic oncology‎
  • 2019‎

Ovarian germ cell tumors (OGCT) are the primary ovarian malignancy affecting girls and young women. Globally, incidence rates and trends for OGCTs have not been compared in the literature and their etiology is not well described. Comparisons of incidence globally could inform etiologic hypotheses. The aim of this analysis was to evaluate geographic variation in OGCT incidence and to identify trends in incidence rates.


Distribution and prognosis of molecular breast cancer subtypes defined by immunohistochemical biomarkers in a Spanish population-based study.

  • M Puig-Vives‎ et al.
  • Gynecologic oncology‎
  • 2013‎

The objective of this study is to analyze the distribution, clinicopathological features, relative survival rate and excess risk of death among females diagnosed with invasive breast cancer and classified by molecular subtype from ten Spanish cancer registries.


Exploring variations in ovarian cancer survival by age and stage (ICBP SurvMark-2): A population-based study.

  • Citadel J Cabasag‎ et al.
  • Gynecologic oncology‎
  • 2020‎

The study aims to evaluate the differences in ovarian cancer survival by age and stage at diagnosis within and across seven high-income countries.


Invasive vulvar extramammary Paget's disease in the United States.

  • Toni P Kilts‎ et al.
  • Gynecologic oncology‎
  • 2020‎

To assess the incidence, treatment, and outcomes in patients with invasive vulvar extramammary Paget's disease (EMPD) in a national cohort of patients.


Younger age distribution of cervical cancer incidence among survivors of pediatric and young adult cancers.

  • Rohit P Ojha‎ et al.
  • Gynecologic oncology‎
  • 2014‎

Pediatric and young adult (PAYA) cancer survivors may have an earlier onset of chronic diseases compared with the general population. We compared the age at cervical cancer diagnosis between PAYA cancer survivors and females in the general US population.


Continuity of care and receipt of aggressive end of life care among women dying of ovarian cancer.

  • Megan A Mullins‎ et al.
  • Gynecologic oncology‎
  • 2021‎

To evaluate the association between post-diagnosis continuity of care and receipt of aggressive end of life care among women dying of ovarian cancer.


Risk of second primary cancer among women with breast cancer: a population-based study in Granada (Spain).

  • Esther Molina-Montes‎ et al.
  • Gynecologic oncology‎
  • 2013‎

The higher risk of developing new cancers in breast cancer survivors is a public health concern. Our aim was to examine risk of second primary cancers among women diagnosed with breast cancer.


Inter-pathologist and pathology report agreement for ovarian tumor characteristics in the Nurses' Health Studies.

  • Mollie E Barnard‎ et al.
  • Gynecologic oncology‎
  • 2018‎

Grade and histotype of ovarian carcinomas are often used as surrogates of molecular subtypes. We examined factors affecting pathologists' reproducibility in two prospective studies.


Ovarian cancer outcomes: Predictors of early death.

  • Renata R Urban‎ et al.
  • Gynecologic oncology‎
  • 2016‎

To describe the outcomes and mortality in advanced ovarian cancer patients in a population-based cohort in the 90 days after diagnosis.


Mortality reduction and cost-effectiveness of performing hysterectomy at the time of risk-reducing salpingo-oophorectomy for prophylaxis against serous/serous-like uterine cancers in BRCA1 mutation carriers.

  • Laura J Havrilesky‎ et al.
  • Gynecologic oncology‎
  • 2017‎

To estimate the survival benefit and cost-effectiveness of performing hysterectomy during risk-reducing salpingo-oophorectomy (RRSO) for BRCA1 mutation carriers.


Intraperitoneal chemotherapy among women in the Medicare population with epithelial ovarian cancer.

  • Kathleen M Fairfield‎ et al.
  • Gynecologic oncology‎
  • 2014‎

Intraperitoneal combined with intravenous chemotherapy (IV/IP) for primary treatment of epithelial ovarian cancer results in a substantial survival advantage for women who are optimally debulked surgically, compared with standard IV only therapy (IV). Little is known about the use of this therapy in the Medicare population.


Impact of adjuvant chemotherapy with radiation for node-positive vulvar cancer: A National Cancer Data Base (NCDB) analysis.

  • Beant S Gill‎ et al.
  • Gynecologic oncology‎
  • 2015‎

For node-positive vulvar cancer, adjuvant radiotherapy has an established benefit, whereas the impact of chemotherapy is unknown. A National Cancer Data Base (NCDB) analysis was conducted to determine patterns of care and evaluate the survival impact of adjuvant chemotherapy.


The elevated risk of ovarian clear cell carcinoma among Asian Pacific Islander women in the United States is not affected by birthplace.

  • Travis-Riley Korenaga‎ et al.
  • Gynecologic oncology‎
  • 2020‎

To determine incidence of ovarian clear cell cancer (OCCC) by race ethnicity and how that relationship is affected by birthplace among Asian Pacific Islanders (API).


Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data.

  • Kara A Michels‎ et al.
  • Gynecologic oncology‎
  • 2019‎

To clarify associations between metabolic syndrome, its components, and ovarian cancer risk.


Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer.

  • Kathleene T Ulanday‎ et al.
  • Gynecologic oncology‎
  • 2014‎

To investigate geographical and socioeconomic variations in performance of lymph node dissection for the evaluation of patients with early-stage epithelial ovarian cancer.


Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women.

  • Haider Mahdi‎ et al.
  • Gynecologic oncology‎
  • 2014‎

To compare survival of Hispanic white (HW) and non-Hispanic white (NHW) women with type II endometrial adenocarcinoma (EC).


Body mass index, physical activity, and mortality in women diagnosed with ovarian cancer: results from the Women's Health Initiative.

  • Yang Zhou‎ et al.
  • Gynecologic oncology‎
  • 2014‎

Ovarian cancer is often diagnosed at late stages and consequently the 5-year survival rate is only 44%. However, there is limited knowledge of the association of modifiable lifestyle factors, such as physical activity and obesity on mortality among women diagnosed with ovarian cancer. The purpose of our study was to prospectively investigate the association of (1) measured body mass index (BMI), and (2) self-reported physical activity with ovarian cancer-specific and all-cause mortality in postmenopausal women enrolled in the Women's Health Initiative (WHI).


Malignant Brenner tumors of the ovary; a population-based analysis.

  • Dimitrios Nasioudis‎ et al.
  • Gynecologic oncology‎
  • 2016‎

Malignant Brenner Tumor (MBT) is a tumor with an extremely low incidence that morphologically resembles to urothelium. Given the paucity of evidence on the epidemiology and prognosis of MBT, the aim of this retrospective population-based study was to elucidate the demographic and clinico-pathological characteristics of patients with ovarian MBT.


Characteristics and prognosis of patients with early-stage endometrial cancer who refuse adjuvant radiotherapy.

  • Martin Koskas‎ et al.
  • Gynecologic oncology‎
  • 2016‎

To investigate the risk factors for refusing adjuvant radiotherapy in patients who have undergone surgery for early-stage endometrial cancer, and to compare their survival rates with patients who have undergone adjuvant radiotherapy.


  1. SciCrunch.org Resources

    Welcome to the FDI Lab - SciCrunch.org Resources search. From here you can search through a compilation of resources used by FDI Lab - SciCrunch.org and see how data is organized within our community.

  2. Navigation

    You are currently on the Community Resources tab looking through categories and sources that FDI Lab - SciCrunch.org has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.

  3. Logging in and Registering

    If you have an account on FDI Lab - SciCrunch.org then you can log in from here to get additional features in FDI Lab - SciCrunch.org such as Collections, Saved Searches, and managing Resources.

  4. Searching

    Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:

    1. Use quotes around phrases you want to match exactly
    2. You can manually AND and OR terms to change how we search between words
    3. You can add "-" to terms to make sure no results return with that term in them (ex. Cerebellum -CA1)
    4. You can add "+" to terms to require they be in the data
    5. Using autocomplete specifies which branch of our semantics you with to search and can help refine your search
  5. Save Your Search

    You can save any searches you perform for quick access to later from here.

  6. Query Expansion

    We recognized your search term and included synonyms and inferred terms along side your term to help get the data you are looking for.

  7. Collections

    If you are logged into FDI Lab - SciCrunch.org you can add data records to your collections to create custom spreadsheets across multiple sources of data.

  8. Facets

    Here are the facets that you can filter your papers by.

  9. Options

    From here we'll present any options for the literature, such as exporting your current results.

  10. Further Questions

    If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.

Publications Per Year

X

Year:

Count: